Organisation paid for research Program year 2024 Source: CMS Open Payments

Alan Kaufman MD, LLC

Neither a doctor nor a teaching hospital

Research payments

$83,333

11 payments

Through program year 2024, Alan Kaufman MD, LLC is reported as receiving $83,333 in research payments, across 11 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$19,338	1
2023	Research	$4,040	2
2022	Research	$6,407	2
2021	Research	$27,988	4
2020	Research	$25,561	2

Breakdown

Who paid Research payments · program years 2020–2024

AstraZeneca Pharmaceuticals LP $65,220 7 payments
AstraZeneca UK Limited $18,113 4 payments

Studies the money was for Research payments · program years 2020–2024

The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod $28,252 3 payments
The CHRONICLE Study is a multi center non interventional prospective cohort study of adults with severe asthma who do not achieve control with high dose inhaled corticosteroid ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibody therapy $28,129 2 payments
Observational Study of Obstructive Lung Disease NOVELTY $18,113 4 payments
A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler $8,839 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.